Get the Daily Brief
Latest Biotech News
Groundbreaking Universal Donor Kidney Transplant Achieved with UBC Enzyme Technology
The University of British Columbia researchers have successfully transplanted a kidney converted from blood type A to universal donor type O using specialized enzymes developed over a decade. This...
AI Discovers Novel Antibiotic Targeting Inflammatory Bowel Disease and Infectious Bacteria
Researchers at McMaster University and MIT have leveraged generative artificial intelligence to pioneer enterololin, a novel narrow-spectrum antibiotic designed to selectively target pathogenic...
Cartography Biosciences Secures $67 Million Series B to Advance Colorectal Cancer Therapeutics
Bay Area startup Cartography Biosciences has closed a $67 million Series B financing led by Pfizer Ventures, aimed at advancing its pipeline of T-cell engaging bispecific and multispecific...
NIH Director Firing Amid Whistleblower Complaint Raises Concerns on Vaccine Policy and Institutional Stability
Dr. Jeanne Marrazzo, former director of NIH's National Institute of Allergy and Infectious Diseases, alleges that she was terminated three weeks after filing a whistleblower complaint concerning...
Amgen’s PCSK9 Inhibitor Repatha Demonstrates Heart Risk Reduction in Broad Prevention Trial
Amgen announced that its cholesterol-lowering injectable drug Repatha significantly reduced risk of heart disease death, heart attack, and stroke in a 12,000-patient clinical trial focusing on...
AI Protein Design Tools Pose Emerging Biosecurity Risks Amid Dual-Use Concerns
A Microsoft-led research team has demonstrated that generative AI protein design platforms can modify toxic proteins to evade current DNA synthesis screening software while maintaining...
Synthetic Biology Advances: Integra Therapeutics Designs Superior Genome-Editing Proteins
Researchers at Integra Therapeutics, in collaboration with Pompeu Fabra University and the Center for Genomic Regulation, have developed and experimentally validated synthetic proteins that...
Unprecedented Genetic Map of Human Metabolism Charts Thousands of Metabolite-Gene Associations
Researchers have created the largest genetic map of human metabolism to date by analyzing data from approximately 450,000 UK Biobank participants across multiple ancestries. Published in Nature...
Amgen’s PCSK9 Drug Sets Heart Risk Prevention Benchmark
Amgen announced compelling data from a 12,000-patient trial demonstrating that its cholesterol-lowering drug Repatha significantly reduces the risk of heart disease death, heart attacks, and...
FDA Approvals Advance Lung Cancer and Abortion Pill Therapies
The U.S. FDA approved Jazz Pharmaceuticals and Roche’s combination as a first-line maintenance therapy for extensive-stage small-cell lung cancer, based on the phase III Imforte study...
Rocket Pharmaceuticals Withdraws Gene Therapy Application for Fanconi Anemia
Following strategic reprioritization, Rocket Pharmaceuticals voluntarily withdrew its FDA biologics license application for RP-L102, a gene therapy targeting Fanconi anemia. The company cited...
Nanyang Biologics Pursues Nasdaq Listing via $1.5 Billion SPAC Deal
Singapore-based Nanyang Biologics has entered a $1.5 billion business combination agreement with Nasdaq-listed special purpose acquisition company RF Acquisition Corp II. The biotech leverages AI...
AI-Driven Protein Design Surpasses Nature in Genome Editing Innovations
Researchers from Integra Therapeutics, in collaboration with Pompeu Fabra University and the Center for Genomic Regulation, have experimentally validated synthetic proteins engineered via...
Breakthrough in Kidney Transplantation: Enzyme Technology Enables Universal Donor Organs
Scientists at the University of British Columbia have successfully conducted the first human transplant of a kidney enzymatically converted from blood type A to universal type O. The enzyme...
Immunotherapy and Cancer Precision Medicine See Advances Through Biomarker and Antibody Development
Several biotech firms and research institutions reported breakthroughs in immuno-oncology. Cartography Biosciences secured a $67 million Series B to progress T-cell engaging bispecific antibodies...
Psilocybin Shows Promise for Dual Relief of Chronic Pain and Depression
Groundbreaking research at the University of Pennsylvania demonstrates that a single dose of psilocybin, the psychoactive compound in psychedelic mushrooms, rapidly and sustainably alleviates pain...
Biopharma Financing Trends Indicate Strategic Shifts Amid Market Uncertainty
Recent analyses reveal that biopharma financings totaled $47.1 billion from January through September 2025, down sharply from $86.7 billion in 2024 during the same period, predominantly due to...
NIH and Federal Science Community Face Impact from Government Shutdown
The ongoing federal government shutdown has led to significant disruptions across U.S. science agencies, notably halting new grant awards from NIH and NSF and suspending various research programs....
FDA Approves Jazz-Roche Lung Cancer Combination Ahead of Schedule
The U.S. Food and Drug Administration has granted early approval for Jazz Pharmaceuticals' and Roche's combination therapy of Zepzelca (lurbinectedin) with Tecentriq (atezolizumab), including...
Rocket Pharmaceuticals Withdraws FDA Application for Fanconi Anemia Gene Therapy
Rocket Pharmaceuticals has voluntarily withdrawn its biologics license application to the FDA for RP-L102, a gene therapy candidate targeting Fanconi anemia, a rare blood disorder. This decision...